20:38 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs Limited, currently under CIRP, has scheduled the 8th meeting of the Committee of Creditors for September 29, 2026, via audio-visual means.
Vivimed Labs Ltd
- Share price
- ₹6.59
- Market cap
- ₹54.64 Cr
- Revenue (annual)
- ₹69.99 Cr
- Net profit (annual)
- ₹-176.5 Cr
- P/E (TTM)
- -0.3×Sector 47.4×
- Promoter holding
- 7.57%-0.20% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Insolvency Petition 4Board Meeting Date 4Other Announcement 2Results Correction 1Legal & Regulatory 1Financial Results 1Debt & Borrowing 1
Time
4 announcements with these filters
16:40 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs, undergoing CIRP, has scheduled the 6th meeting of the Committee of Creditors for August 18, 2026, as per regulatory requirements.
13:14 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs Limited has entered Corporate Insolvency Resolution Process (CIRP) following an NCLT Bengaluru Bench order dated April 15, 2026. T Narayana Swamy has been appointed as the Interim Resolution Professional. Creditors are called to submit claims by May 01, 2026, with an estimated resolution process closure date of October 11, 2026.
- Execution
- Estimated date of closure: 11.10.2026
16:03 IST
BSE
Insolvency Petition
Vivimed Labs Insolvency Petition
Vivimed Labs Limited has been admitted into the Corporate Insolvency Resolution Process (CIRP) by the NCLT, Bengaluru Bench. The action follows a petition by operational creditor Blue Cube Germany Assets GmbH over a ₹2.78 Crore default. Shri T Narayana Swamy has been appointed as the Interim Resolution Professional, and a moratorium has been declared.
- Value
- ₹2.78 Cr